The treatment is commonly used in integrative medicine practices for individuals seeking improved energy, skin clarity, cognitive performance, and metabolic function
Brain cell metabolism was preserved in one trial, and the other found reduced amyloid-beta in extracellular vesicles, but neither trial found that GLP-1 drugs reduced the build-up of amyloid-beta in the brain or helped stave off cognitive decline
Gradual caloric reduction helps prevent sudden drops in blood pressure or perfusion, he said
The core principles haven't changed from what works with current GLP-1 medications
Injectable Wegovy has demonstrated approximately 15% weight loss in clinical trials, while Eli Lillys Zepbounda dual GIP/GLP-1 agonistshows approximately 21% weight loss at its highest dose
Conclusion Ozempic (along with some of the similar drugs being identified) represents a promising therapeutic option not only for managing type 2 diabetes but also for weight loss